Rubrica n°1 – 27 Febbraio 2023
Paper n. 1
Randomized, Multicenter, Phase 3 Study of Accelerated Fraction Radiation Therapy with Concomitant Boost to the Gross Tumor Volume Compared With Conventional Fractionation in Concurrent Chemoradiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: The Korean Radiation Oncology Group 09-03 Trial.
Kim YH, Ahn SJ, Moon SH, Kim JH, Kim YC, Oh IJ, et al.Int J Radiat Oncol Biol Phys. 2022 Oct 21;S0360-3016(22)03440-X.
Paper n.2
18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): results from a randomised clinical trial.
SA. Cooke, Prof D de Ruysscher, B Reymen, M Lambrecht, GF Persson, Corinne Faivre-Finn, EMT. Dieleman, R Lewensohn, JNA. van Diessen, K Sikorska, F Lalezari, W Vogel, W van Elmpt, EMF Damen, J-J Sonke, JSA Belderbos.
Radiother Oncol. 2023 Jan 24:109492. doi: 10.1016/j.radonc.2023.109492. Online ahead of print.Visualizza Documento
Rubrica n°9 – 24 Luglio 2023
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
Bogart J, Wang X, Masters G, et al.
JCO [Internet] 2023 [cited 2023 May 15];41(13):2394–402. Available from: https://ascopubs.org/doi/10.1200/JCO.22.01359
DOI: 10.1200/JCO.22.01359